Edwards Lifesciences United States — Goodwill (Note 11) decreased by 1.3% to $1.12B in Q4 2025 compared to the prior quarter. Year-over-year, this metric declined by 1.3%, from $1.14B to $1.12B.
An increase suggests recent acquisitions or adjustments in the U.S. segment, while a decrease may indicate impairment charges or divestitures.
Represents the total carrying value of goodwill allocated to the United States geographic reporting segment. This asset...
Standard across most public companies reporting segment-level intangible assets under GAAP.
ew_segment_united_states_goodwill_note_11| Q4 '21 | Q4 '22 | Q4 '23 | Q4 '24 | Q4 '25 | |
|---|---|---|---|---|---|
| Value | $773.70M | $773.70M | $773.70M | $1.14B | $1.12B |
| QoQ Change | — | +0.0% | +0.0% | +47.3% | -1.3% |
| YoY Change | — | +0.0% | +0.0% | +47.3% | -1.3% |